Gross-to-Net
The discount between a drug’s list price and what the manufacturer actually receives, after rebates to payers and pharmacy benefit managers, discounts, chargebacks and co-pay assistance. Commonly 20% to 50% in the US and growing over a product’s life. A launch curve built on the gross price overstates revenue by exactly this margin.
Where Gross-to-Net comes up
Keep reading
Biotech rNPV valuation guideRelated Healthcare terms
Go further than reading
The written material is free. These are the ways to get it applied to your own work.
CV Review by a Human
Written margin-note feedback on structure, impact bullets and ATS-readability. Reviewed by Suro, not an AI score.
$25 48h turnaround
Cover Letter Review by a Human
Line-by-line review of argument, tailoring and tone, with a rewritten opening as a worked example.
$50 48h turnaround
L3VLUP Pro
The subscription: personalised alerts, Apply Packs, every answer marked, full history and the whole research library.
$25 /month
Browse the full glossary — 293 finance recruiting and technical terms, in plain English.